Acquisition Momentum Schülke & Mayr has a history of acquisitions to expand capabilities and market reach, including recent and past deals in healthcare, cleanroom containment, and infection prevention. This signals openness to partnerships that complement or extend product lines, enabling cross-sell of hygiene, disinfection, and infection control solutions.

Global Footprint With products sold in over 100 countries via 20 subsidiaries and three production sites, there is strong international exposure and potential for region-specific sanitation, infection prevention, and cosmetic care product initiatives. Leverage to propose localized regulatory-compliant solutions and global supply chain support.

Healthcare Focus Core emphasis on hygiene, infection prevention and patient care presents opportunities to upsell advanced disinfectants, antiseptics, and infection-control technologies to hospitals, clinics, and long-term care facilities, including cleanroom and medical device environments.

Sustainability & Innovation Private equity involvement with a stated focus on sustainability and innovation suggests a willingness to invest in greener formulations, safer chemistries, and digital solutions that improve compliance and monitoring—areas ripe for partnership in product development and sustainability-linked offerings.

Digital & Data-Driven Adoption of modern tech stack including Salesforce Marketing Cloud and data platforms indicates readiness for digital engagement, CRM-driven campaigns, and data-backed customer insights. This supports targeted, multi-channel sales outreach and lifecycle programs for enterprise and institutional buyers.